Legal briefing: Alzheimer's drug ruling

The High Court hearing this year over the issue of the NHS funding drugs for treating Alzheimer's disease forced NICE to state its principles with great clarity. Now it has to stick to them, says David Lock

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here